189 related articles for article (PubMed ID: 38302841)
21. Identification of host gene-microbiome associations in colorectal cancer patients using mendelian randomization.
Xiang Y; Zhang C; Wang J; Cheng Y; Wang L; Tong Y; Yan D
J Transl Med; 2023 Aug; 21(1):535. PubMed ID: 37563724
[TBL] [Abstract][Full Text] [Related]
22. Different Characteristics in Gut Microbiome between Advanced Adenoma Patients and Colorectal Cancer Patients by Metagenomic Analysis.
Han S; Zhuang J; Pan Y; Wu W; Ding K
Microbiol Spectr; 2022 Dec; 10(6):e0159322. PubMed ID: 36453905
[TBL] [Abstract][Full Text] [Related]
23. Exploring the Role of Gut Microbiome in Colon Cancer.
Chattopadhyay I; Dhar R; Pethusamy K; Seethy A; Srivastava T; Sah R; Sharma J; Karmakar S
Appl Biochem Biotechnol; 2021 Jun; 193(6):1780-1799. PubMed ID: 33492552
[TBL] [Abstract][Full Text] [Related]
24. Gut mucosal microbiota profiles linked to colorectal cancer recurrence.
Huo RX; Wang YJ; Hou SB; Wang W; Zhang CZ; Wan XH
World J Gastroenterol; 2022 May; 28(18):1946-1964. PubMed ID: 35664963
[TBL] [Abstract][Full Text] [Related]
25. Portulaca oleracea extract reduces gut microbiota imbalance and inhibits colorectal cancer progression via inactivation of the Wnt/β-catenin signaling pathway.
Yi S; Jin X; Liu B; Wu P; Xiao W; Chen W
Phytomedicine; 2022 Oct; 105():154279. PubMed ID: 35963192
[TBL] [Abstract][Full Text] [Related]
26. Functional genomic analyses of the gut microbiota for CRC screening.
Konstantinov SR; Kuipers EJ; Peppelenbosch MP
Nat Rev Gastroenterol Hepatol; 2013 Dec; 10(12):741-5. PubMed ID: 24042452
[TBL] [Abstract][Full Text] [Related]
27. Aging characteristics of colorectal cancer based on gut microbiota.
Wu Y; Zhuang J; Zhang Q; Zhao X; Chen G; Han S; Hu B; Wu W; Han S
Cancer Med; 2023 Sep; 12(17):17822-17834. PubMed ID: 37548332
[TBL] [Abstract][Full Text] [Related]
28. Interplay between Dietary Polyphenols and Oral and Gut Microbiota in the Development of Colorectal Cancer.
Cueva C; Silva M; Pinillos I; Bartolomé B; Moreno-Arribas MV
Nutrients; 2020 Feb; 12(3):. PubMed ID: 32120799
[TBL] [Abstract][Full Text] [Related]
29. Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection.
Abernathy-Close L; Barron MR; George JM; Dieterle MG; Vendrov KC; Bergin IL; Young VB
mBio; 2021 Jun; 12(3):e0273320. PubMed ID: 34126769
[TBL] [Abstract][Full Text] [Related]
30. Study of the Relationship between Microbiome and Colorectal Cancer Susceptibility Using 16SrRNA Sequencing.
Liu W; Zhang R; Shu R; Yu J; Li H; Long H; Jin S; Li S; Hu Q; Yao F; Zhou C; Huang Q; Hu X; Chen M; Hu W; Wang Q; Fang S; Wu Q
Biomed Res Int; 2020; 2020():7828392. PubMed ID: 32083132
[TBL] [Abstract][Full Text] [Related]
31. Role of gut microbiota and bacterial metabolites in mucins of colorectal cancer.
Gu M; Yin W; Zhang J; Yin J; Tang X; Ling J; Tang Z; Yin W; Wang X; Ni Q; Zhu Y; Chen T
Front Cell Infect Microbiol; 2023; 13():1119992. PubMed ID: 37265504
[TBL] [Abstract][Full Text] [Related]
32. Relationships of Gut Microbiota Composition, Short-Chain Fatty Acids and Polyamines with the Pathological Response to Neoadjuvant Radiochemotherapy in Colorectal Cancer Patients.
Sánchez-Alcoholado L; Laborda-Illanes A; Otero A; Ordóñez R; González-González A; Plaza-Andrades I; Ramos-Molina B; Gómez-Millán J; Queipo-Ortuño MI
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502456
[TBL] [Abstract][Full Text] [Related]
33. Host⁻MicroRNA⁻Microbiota Interactions in Colorectal Cancer.
Yuan C; Steer CJ; Subramanian S
Genes (Basel); 2019 Apr; 10(4):. PubMed ID: 30987065
[TBL] [Abstract][Full Text] [Related]
34. Traditional Medicine Pien Tze Huang Suppresses Colorectal Tumorigenesis Through Restoring Gut Microbiota and Metabolites.
Gou H; Su H; Liu D; Wong CC; Shang H; Fang Y; Zeng X; Chen H; Li Y; Huang Z; Fan M; Wei C; Wang X; Zhang X; Li X; Yu J
Gastroenterology; 2023 Dec; 165(6):1404-1419. PubMed ID: 37704113
[TBL] [Abstract][Full Text] [Related]
35. The gut microbiota can orchestrate the signaling pathways in colorectal cancer.
Bennedsen ALB; Furbo S; Bjarnsholt T; Raskov H; Gögenur I; Kvich L
APMIS; 2022 Mar; 130(3):121-139. PubMed ID: 35007370
[TBL] [Abstract][Full Text] [Related]
36. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment.
Hanus M; Parada-Venegas D; Landskron G; Wielandt AM; Hurtado C; Alvarez K; Hermoso MA; López-Köstner F; De la Fuente M
Front Immunol; 2021; 12():612826. PubMed ID: 33841394
[TBL] [Abstract][Full Text] [Related]
37. A systems biology approach to predict and characterize human gut microbial metabolites in colorectal cancer.
Wang Q; Li L; Xu R
Sci Rep; 2018 Apr; 8(1):6225. PubMed ID: 29670137
[TBL] [Abstract][Full Text] [Related]
38. The Colorectal Cancer Microbiota Alter Their Transcriptome To Adapt to the Acidity, Reactive Oxygen Species, and Metabolite Availability of Gut Microenvironments.
Lamaudière MTF; Arasaradnam R; Weedall GD; Morozov IY
mSphere; 2023 Apr; 8(2):e0062722. PubMed ID: 36847536
[TBL] [Abstract][Full Text] [Related]
39. Implication of gut microbes and its metabolites in colorectal cancer.
Kumar A; Ali A; Kapardar RK; Dar GM; Nimisha ; Apurva ; Sharma AK; Verma R; Sattar RSA; Ahmad E; Mahajan B; Saluja SS
J Cancer Res Clin Oncol; 2023 Jan; 149(1):441-465. PubMed ID: 36572792
[TBL] [Abstract][Full Text] [Related]
40. Metformin Regulates Gut Microbiota Abundance to Suppress M2 Skewing of Macrophages and Colorectal Tumorigenesis in Mice.
Fan L; Zeng X; Xu G
J Microbiol; 2023 Jan; 61(1):109-120. PubMed ID: 36701104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
